Updates to the Drug Benefit List - Winter 2005-2006
Additions for all but Quebec
Additions for Quebec
Delisted Benefits
Drugs Discontinued by the Manufacturer
Replacement DINs (Drug Identification Number)
Change in Status
Name Change
Limited Use Benefits
Drug Benefit List: Additions for all but Quebec
Winter 2005-2006
This Winter update identifies changes made to the Non-Insured Health
Benefits (NIHB) Drug Benefit List (DBL) since the last update (Fall 2005).
The recent changes announced in this Winter 2005-2006 update are not
reflected in the electronic version of the NIHB DBL on the website. Please
refer to the Web site at the following URL Address:
www.hc-sc.gc.ca/fnihb/nihb/pharmacy/drugbenefitlist/benefitupdateindex.htm
Effective Date: 2005-09-01
DIN |
MFR |
BRAND NAME |
PTC |
02260077 |
APX |
APO-BRIMONIDINE 0.2% OPHTH SOLUTION |
52:36.00 |
02257661 |
BCI |
BCI-FLUVOXAMINE 50MG TABLET |
28:16.04 |
02257688 |
BCI |
BCI-FLUVOXAMINE 100MG TABLET |
28:16.04 |
02259583 |
BAK |
BCI-SALBUTAMOL 1MG/ML INHALATION SOLUTION |
12:12.00 |
02253054 |
GEN |
GEN-ANAGRELIDE 0.5MG CAPSULE |
92:00.00 |
02265273 |
NOP |
NOVO-WARFARIN 1MG TABLET |
20:12.04 |
02265281 |
NOP |
NOVO-WARFARIN 2MG TABLET |
20:12.04 |
02265303 |
NOP |
NOVO-WARFARIN 2.5MG TABLET |
20:12.04 |
02265311 |
NOP |
NOVO-WARFARIN 3MG TABLET |
20:12.04 |
02265338 |
NOP |
NOVO-WARFARIN 4MG TABLET |
20:12.04 |
02265346 |
NOP |
NOVO-WARFARIN 5MG TABLET |
20:12.04 |
02264749 |
TAR |
TARO-MOMETASONE 0.1% OINTMENT |
84:06.00 |
02250896 |
TAR |
TARO-PHENYTOIN 25MG/ML SUSPENSION |
28:12.12 |
Effective Date: 2005-10-01
DIN |
MFR |
BRAND NAME |
PTC |
02267640 |
APX |
APO-MEDROXY 100MG TABLET |
68:32.00 |
01929925 |
AVT |
LARGACTIL 50MG TABLET |
28:16.04 |
02253550 |
PDL |
MEDROXY 2.5MG TABLET |
68:32.00 |
02253577 |
PDL |
MEDROXY 5MG TABLET |
68:32.00 |
02265885 |
TAR |
TARO-SIMVASTATIN 10MG TABLET |
24:06.08 |
02265893 |
TAR |
TARO-SIMVASTATIN 20MG TABLET |
24:06.08 |
02265907 |
TAR |
TARO-SIMVASTATIN 40MG TABLET |
24:06.08 |
Effective Date: 2005-11-01
DIN |
MFR |
BRAND NAME |
PTC |
02230435 |
PMS |
ACET 160MG SUPPOSITORY |
28:08.92 |
02255251 |
PMT |
ACETAMINOPHEN 500MG TABLET |
28:08.92 |
00549703 |
PMT |
ACETAMINOPHEN 500MG TABLET |
28:08.92 |
02252813 |
PMT |
ACETAMINOPHEN 500MG TABLET |
28:08.92 |
02263130 |
APX |
APO-CIPROFLOX 0.3% OPHTH SOLUTION |
52:04.04 |
02268388 |
APX |
APO-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02268396 |
APX |
APO-SUMATRIPTAN 100MG TABLET |
28:32.28 |
00785547 |
PMS |
ASA 150MG SUPPOSITORY |
28:08.04 |
00582867 |
PMS |
ASA 650MG SUPPOSITORY |
28:08.04 |
02257882 |
COB |
CO-SUMATRIPTAN 25MG TABLET |
28:32.28 |
02257890 |
COB |
CO-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02257904 |
COB |
CO-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02265540 |
AZC |
CRESTOR 5MG TABLET |
24:06.08 |
02257378 |
GEN |
GEN-AMILAZIDE 5MG & 50MG TABLET |
40:28.00 |
02257092 |
GEN |
GEN-PRAVASTATIN 10MG TABLET |
24:06.08 |
02257106 |
GEN |
GEN-PRAVASTATIN 20MG TABLET |
24:06.08 |
02257114 |
GEN |
GEN-PRAVASTATIN 40MG TABLET |
24:06.08 |
02268906 |
GEN |
GEN-SUMATRIPTAN 25MG TABLET |
28:32.28 |
02268914 |
GEN |
GEN-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02268922 |
GEN |
GEN-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02263351 |
GEN |
GEN-TOPIRAMATE 25MG TABLET |
28:12.92 |
02263378 |
GEN |
GEN-TOPIRAMATE 100MG TABLET |
28:12.92 |
02263386 |
GEN |
GEN-TOPIRAMATE 200MG TABLET |
28:12.92 |
02239738 |
GSK |
IMITREX DF 25MG TABLET |
28:32.38 |
02239367 |
NOP |
NOVO-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02248860 |
NOP |
NOVO-TOPIRAMATE 25MG TABLET |
28:12.92 |
02248861 |
NOP |
NOVO-TOPIRAMATE 100MG TABLET |
28:12.92 |
02248862 |
NOP |
NOVO-TOPIRAMATE 200MG TABLET |
28:12.92 |
02256428 |
PMS |
PMS-SUMATRIPTAN 25MG TABLET |
28:32.28 |
02256436 |
PMS |
PMS-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02256444 |
PMS |
PMS-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02262991 |
PMS |
PMS-TOPIRAMATE 25MG TABLET |
28:12.92 |
02263009 |
PMS |
PMS-TOPIRAMATE 100MG TABLET |
28:12.92 |
02263017 |
PMS |
PMS-TOPIRAMATE 200MG TABLET |
28:12.92 |
02267985 |
RBY |
RAN-ATENOLOL 50MG TABLET |
24:24.00 |
02267993 |
RBY |
RAN-ATENOLOL 100MG TABLET |
24:24.00 |
02267934 |
RBY |
RAN-CIPROFLOXACIN 250MG TABLET |
08:12.18 |
02267942 |
RBY |
RAN-CIPROFLOXACIN 500MG TABLET |
08:12.18 |
02267950 |
RBY |
RAN-CIPROFLOXACIN 750MG TABLET |
08:12.18 |
02268000 |
RBY |
RAN-CITALOPRAM 20MG TABLET |
28:16.04 |
02268019 |
RBY |
RAN-CITALOPRAM 40MG TABLET |
28:16.04 |
02268078 |
RBY |
RAN-DOMPERIDONE 10MG TABLET |
56:22.92 |
02267969 |
RBY |
RAN-LOVASTATIN 20MG TABLET |
24:06.08 |
02267977 |
RBY |
RAN-LOVASTATIN 40MG TABLET |
24:06.08 |
02269031 |
RBY |
RAN-METFORMIN 500MG TABLET |
68:20.04 |
02269058 |
RBY |
RAN-METFORMIN 850MG TABLET |
68:20.04 |
02260913 |
RPH |
RATIO-GABAPENTIN 600MG TABLET |
28:12.92 |
02260921 |
RPH |
RATIO-GABAPENTIN 800MG TABLET |
28:12.92 |
02256827 |
RPH |
RATIO-TOPIRAMATE 25MG TABLET |
28:12.92 |
02256835 |
RPH |
RATIO-TOPIRAMATE 100MG TABLET |
28:12.92 |
02256843 |
RPH |
RATIO-TOPIRAMATE 200MG TABLET |
28:12.92 |
02263025 |
RHO |
RHOXAL-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02263033 |
RHO |
RHOXAL-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02260050 |
RHO |
RHOXAL-TOPIRAMATE 25MG TABLET |
28:12.92 |
02260069 |
RHO |
RHOXAL-TOPIRAMATE 100MG TABLET |
28:12.92 |
02267837 |
RHO |
RHOXAL-TOPIRAMATE 200MG TABLET |
28:12.92 |
02258560 |
JNO |
TRI-CYCLEN LO (21) TABLET |
68:12.00 |
02258587 |
JNO |
TRI-CYCLEN LO (28) TABLET |
68:12.00 |
Effective Date: 2005-12-01
DIN |
MFR |
BRAND NAME |
PTC |
97799815 |
ROD |
ACCU-CHEK AVIVA (50) TEST STRIPS |
36:26.00 |
97799814 |
ROD |
ACCU-CHEK AVIVA (100) TEST STRIPS |
36:26.00 |
97799817 |
ROD |
ACCU-CHEK MULTICLIX LANCET |
94:01.00 |
97799819 |
THS |
FREESTYLE MINI GLUCOMETER |
94:01.00 |
02244551 |
MAY |
PAMIDRONATE DISODIUM 60MG INJECTION |
92:00.00 |
02264951 |
RHO |
RHOXAL-PAMIDRONATE 30MG INJECTION |
92:00.00 |
02264978 |
RHO |
RHOXAL-PAMIDRONATE 60MG INJECTION |
92:00.00 |
02264986 |
RHO |
RHOXAL-PAMIDRONATE 90MG INJECTION |
92:00.00 |
Drug Benefit List: Additions for Quebec
Winter 2005-2006
This Winter update identifies changes made to the NIHB Drug Benefit
List (DBL) since the last update (Fall 2005).
The recent changes announced in this Winter 2005-2006 update are not
reflected in the electronic version of the NIHB DBL. Please refer to
the Web site at the following URL Address:
www.hc-sc.gc.ca/fnihb/nihb/pharmacy/drugbenefitlist/benefitupdateindex.htm
Effective Date: 2005-09-01
DIN |
MFR |
BRAND NAME |
PTC |
02260077 |
APX |
APO-BRIMONIDINE 0.2% OPHTH SOLUTION |
52:36.00 |
02257661 |
BCI |
BCI-FLUVOXAMINE 50MG TABLET |
28:16.04 |
02257688 |
BCI |
BCI-FLUVOXAMINE 100MG TABLET |
28:16.04 |
02259583 |
BAK |
BCI-SALBUTAMOL 1MG/ML INHALATION SOLUTION |
12:12.00 |
02253054 |
GEN |
GEN-ANAGRELIDE 0.5MG CAPSULE |
92:00.00 |
02265273 |
NOP |
NOVO-WARFARIN 1MG TABLET |
20:12.04 |
02265281 |
NOP |
NOVO-WARFARIN 2MG TABLET |
20:12.04 |
02265303 |
NOP |
NOVO-WARFARIN 2.5MG TABLET |
20:12.04 |
02265311 |
NOP |
NOVO-WARFARIN 3MG TABLET |
20:12.04 |
02265338 |
NOP |
NOVO-WARFARIN 4MG TABLET |
20:12.04 |
02265346 |
NOP |
NOVO-WARFARIN 5MG TABLET |
20:12.04 |
02264749 |
TAR |
TARO-MOMETASONE 0.1% OINTMENT |
84:06.00 |
02250896 |
TAR |
TARO-PHENYTOIN 25MG/ML SUSPENSION |
28:12.12 |
Effective Date: 2005-10-01
DIN |
MFR |
BRAND NAME |
PTC |
02267640 |
APX |
APO-MEDROXY 100MG TABLET |
68:32.00 |
01929925 |
AVT |
LARGACTIL 50MG TABLET |
28:16.04 |
02253550 |
PDL |
MEDROXY 2.5MG TABLET |
68:32.00 |
02253577 |
PDL |
MEDROXY 5MG TABLET |
68:32.00 |
02265885 |
TAR |
TARO-SIMVASTATIN 10MG TABLET |
24:06.08 |
02265893 |
TAR |
TARO-SIMVASTATIN 20MG TABLET |
24:06.08 |
02265907 |
TAR |
TARO-SIMVASTATIN 40MG TABLET |
24:06.08 |
Effective Date: 2005-11-01
DIN |
MFR |
BRAND NAME |
PTC |
02230435 |
PMS |
ACET 160MG SUPPOSITORY |
28:08.92 |
02255251 |
PMT |
ACETAMINOPHEN 500MG TABLET |
28:08.92 |
00549703 |
PMT |
ACETAMINOPHEN 500MG TABLET |
28:08.92 |
02252813 |
PMT |
ACETAMINOPHEN 500MG TABLET |
28:08.92 |
02263130 |
APX |
APO-CIPROFLOX 0.3% OPHTH SOLUTION |
52:04.04 |
02268388 |
APX |
APO-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02268396 |
APX |
APO-SUMATRIPTAN 100MG TABLET |
28:32.28 |
00785547 |
PMS |
ASA 150MG SUPPOSITORY |
28:08.04 |
00582867 |
PMS |
ASA 650MG SUPPOSITORY |
28:08.04 |
02257882 |
COB |
CO-SUMATRIPTAN 25MG TABLET |
28:32.28 |
02257890 |
COB |
CO-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02257904 |
COB |
CO-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02265540 |
AZC |
CRESTOR 5MG TABLET |
24:06.08 |
02257378 |
GEN |
GEN-AMILAZIDE 5MG & 50MG TABLET |
40:28.00 |
02257092 |
GEN |
GEN-PRAVASTATIN 10MG TABLET |
24:06.08 |
02257106 |
GEN |
GEN-PRAVASTATIN 20MG TABLET |
24:06.08 |
02257114 |
GEN |
GEN-PRAVASTATIN 40MG TABLET |
24:06.08 |
02268906 |
GEN |
GEN-SUMATRIPTAN 25MG TABLET |
28:32.28 |
02268914 |
GEN |
GEN-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02268922 |
GEN |
GEN-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02263351 |
GEN |
GEN-TOPIRAMATE 25MG TABLET |
28:12.92 |
02263378 |
GEN |
GEN-TOPIRAMATE 100MG TABLET |
28:12.92 |
02263386 |
GEN |
GEN-TOPIRAMATE 200MG TABLET |
28:12.92 |
02239738 |
GSK |
IMITREX DF 25MG TABLET |
28:32.38 |
02239367 |
NOP |
NOVO-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02248860 |
NOP |
NOVO-TOPIRAMATE 25MG TABLET |
28:12.92 |
02248861 |
NOP |
NOVO-TOPIRAMATE 100MG TABLET |
28:12.92 |
02248862 |
NOP |
NOVO-TOPIRAMATE 200MG TABLET |
28:12.92 |
02256428 |
PMS |
PMS-SUMATRIPTAN 25MG TABLET |
28:32.28 |
02256436 |
PMS |
PMS-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02256444 |
PMS |
PMS-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02262991 |
PMS |
PMS-TOPIRAMATE 25MG TABLET |
28:12.92 |
02263009 |
PMS |
PMS-TOPIRAMATE 100MG TABLET |
28:12.92 |
02263017 |
PMS |
PMS-TOPIRAMATE 200MG TABLET |
28:12.92 |
02267985 |
RBY |
RAN-ATENOLOL 50MG TABLET |
24:24.00 |
02267993 |
RBY |
RAN-ATENOLOL 100MG TABLET |
24:24.00 |
02267934 |
RBY |
RAN-CIPROFLOXACIN 250MG TABLET |
08:12.18 |
02267942 |
RBY |
RAN-CIPROFLOXACIN 500MG TABLET |
08:12.18 |
02267950 |
RBY |
RAN-CIPROFLOXACIN 750MG TABLET |
08:12.18 |
02268000 |
RBY |
RAN-CITALOPRAM 20MG TABLET |
28:16.04 |
02268019 |
RBY |
RAN-CITALOPRAM 40MG TABLET |
28:16.04 |
02268078 |
RBY |
RAN-DOMPERIDONE 10MG TABLET |
56:22.92 |
02267969 |
RBY |
RAN-LOVASTATIN 20MG TABLET |
24:06.08 |
02267977 |
RBY |
RAN-LOVASTATIN 40MG TABLET |
24:06.08 |
02269031 |
RBY |
RAN-METFORMIN 500MG TABLET |
68:20.04 |
02269058 |
RBY |
RAN-METFORMIN 850MG TABLET |
68:20.04 |
02260913 |
RPH |
RATIO-GABAPENTIN 600MG TABLET |
28:12.92 |
02260921 |
RPH |
RATIO-GABAPENTIN 800MG TABLET |
28:12.92 |
02256827 |
RPH |
RATIO-TOPIRAMATE 25MG TABLET |
28:12.92 |
02256835 |
RPH |
RATIO-TOPIRAMATE 100MG TABLET |
28:12.92 |
02256843 |
RPH |
RATIO-TOPIRAMATE 200MG TABLET |
28:12.92 |
02263025 |
RHO |
RHOXAL-SUMATRIPTAN 50MG TABLET |
28:32.28 |
02263033 |
RHO |
RHOXAL-SUMATRIPTAN 100MG TABLET |
28:32.28 |
02260050 |
RHO |
RHOXAL-TOPIRAMATE 25MG TABLET |
28:12.92 |
02260069 |
RHO |
RHOXAL-TOPIRAMATE 100MG TABLET |
28:12.92 |
02267837 |
RHO |
RHOXAL-TOPIRAMATE 200MG TABLET |
28:12.92 |
02258560 |
JNO |
TRI-CYCLEN LO (21) TABLET |
68:12.00 |
02258587 |
JNO |
TRI-CYCLEN LO (28) TABLET |
68:12.00 |
Effective Date: 2005-12-01
DIN |
MFR |
BRAND NAME |
PTC |
97799815 |
ROD |
ACCU-CHEK AVIVA (50) TEST STRIPS |
36:26.00 |
97799814 |
ROD |
ACCU-CHEK AVIVA (100) TEST STRIPS |
36:26.00 |
97799817 |
ROD |
ACCU-CHEK MULTICLIX LANCET |
94:01.00 |
97799819 |
THS |
FREESTYLE MINI GLUCOMETER |
94:01.00 |
02244551 |
MAY |
PAMIDRONATE DISODIUM 60MG INJECTION |
92:00.00 |
02264951 |
RHO |
RHOXAL-PAMIDRONATE 30MG INJECTION |
92:00.00 |
02264978 |
RHO |
RHOXAL-PAMIDRONATE 60MG INJECTION |
92:00.00 |
02264986 |
RHO |
RHOXAL-PAMIDRONATE 90MG INJECTION |
92:00.00 |
Delisted Benefits
There are no delisted items for the Winter 2005-2006 update.
Drugs Discontinued by the Manufacturer
Winter 2005-2006
This Winter update identifies changes made to the NIHB Drug Benefit
List (DBL) since the last update (Fall 2005).
The recent changes announced in this Winter 2005-2006 update are not
reflected in the electronic version of the NIHB DBL. Please refer to
the Web site at the following URL Address:
www.hc-sc.gc.ca/fnihb/nihb/pharmacy/drugbenefitlist/benefitupdateindex.htm
DIN |
MFR |
BRAND NAME |
PTC |
00360228 |
APX |
APO-THIORIDAZINE 10MG TABLET |
28:16.08 |
00360198 |
APX |
APO-THIORIDAZINE 25MG TABLET |
28:16.08 |
00360236 |
APX |
APO-THIORIDAZINE 50MG TABLET |
28:16.08 |
00360244 |
APX |
APO-THIORIDAZINE 100MG TABLET |
28:16.08 |
02150433 |
BCD |
FLINTSTONES MULTIPLE VITAMIN CHEWABLE TABLET |
88:28.00 |
02174677 |
NOP |
NOVO-DIFENAC 50MG SUPPOSITORY |
28:08.04 |
02174685 |
NOP |
NOVO-DIFENAC 100MG SUPPOSITORY |
28:08.04 |
01917021 |
LIL |
PROZAC 4MG/ML LIQUID |
28:16.04 |
00888524 |
RPH |
RATIO-DILTIAZEM 30MG TABLET |
24:28.92 |
00888532 |
RPH |
RATIO-DILTIAZEM 60MG TABLET |
24:28.92 |
02139995 |
RPH |
RATIO-PRAZOSIN 5MG TABLET |
24:20.00 |
00685933 |
RPH |
SULFASALAZINE 500MG TABLET |
08:12.20 |
00386553 |
PRO |
THIORIDAZINE 10MG TABLET |
28:16.08 |
00386545 |
PRO |
THIORIDAZINE 25MG TABLET |
28:16.08 |
00386537 |
PRO |
THIORIDAZINE 50MG TABLET |
28:16.08 |
00456381 |
PDL |
THIORIDAZINE 100MG TABLET |
28:16.08 |
Replacement DINs (Drug Identification Number)
There are no replacement DINs (Drug Identification Number) for the Winter
2005-2006 update.
Change in Status
There are no change in status for the Winter 2005-2006 update.
Name Change
There are no name changes for the Winter 2005-2006 update.
Limited Use Benefits
Winter 2005-2006
This Winter update identifies changes made to the NIHB Drug Benefit
List (DBL) since the last update (Fall 2005). Please refer to the Web
site at the following URL address for the criteria:
www.hc-sc.gc.ca/fnihb/nihb/pharmacy/drugbenefitlist/limitedusebenefits/criteria.htm
The recent changes announced in this Winter 2005-2006 update are not
reflected in the electronic version of the NIHB DBL. Please refer to
the Web site at the following URL Address:
www.hc-sc.gc.ca/fnihb/nihb/pharmacy/drugbenefitlist/benefitupdateindex.htm
Effective Date: 2005-11-01
DIN |
MFR |
BRAND NAME |
PTC |
02268027 |
RBY |
RAN-CARVEDILOL 3.125MG TABLET |
24:24.00 |
02268035 |
RBY |
RAN-CARVEDILOL 6.25MG TABLET |
24:24.00 |
02268043 |
RBY |
RAN-CARVEDILOL 12.5MG TABLET |
24:24.00 |
02268051 |
RBY |
RAN-CARVEDILOL 25MG TABLET |
24:24.00 |
|